Carboplatin-oral etoposide personalised dosing in elderly non-small cell lung cancer patients

By Frasci G.   Comella P.   Panza N.   De Cataldis G.   Del Gaizo F.   Pozzo C.   Gravina A.   Ruffolo P.   Cioffi R.   Marcatili P.   Della Vittoria M.   Monfardini S.   Comella G.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1710-1714

Elsevier

Access to resources Recommend Favorite

Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate?

By Hatton M.Q.F.   Cassidy J.   Bicknell S.   Semple P.   Stack B.   Steward W.P.   West of Scotland Lung Cancer Group  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1022-1023

Elsevier

Access to resources Recommend Favorite

Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer

By Baandrup Louise   Hauggaard Anders   Winberg Birgitte H.   Holm Bente  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 465-467

Informa Healthcare

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite